Fatal Disseminated Strongyloidiasis in an Immunosuppressed Patient During COVID-19 Pandemic.
Disseminated strongyloidiasis
Immunosuppressive therapy
Myasthenia gravis
Strongyloides stercoralis
Journal
Acta parasitologica
ISSN: 1896-1851
Titre abrégé: Acta Parasitol
Pays: Switzerland
ID NLM: 9301947
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
26
04
2023
accepted:
20
07
2023
medline:
29
8
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
ppublish
Résumé
This report presents a fatal case of disseminated strongyloidiasis in a patient with myasthenia gravis and diabetes mellitus who had received corticosteroid therapy. The patient was a 67-year-old woman living in a rural area endemic for Strongyloides stercoralis in northern Iran. Disseminated strongyloidiasis was diagnosed in the advanced stage of the disease, with enormous numbers of larvae demonstrated in direct smears prepared from stool samples and stomach biopsy. Despite treatment with ivermectin and antibiotics, the patient succumbed to the severity of the infection. Clinicians working in endemic areas should be mindful of the possibility of gastric involvement in strongyloidiasis, even if symptoms are nonspecific. We recommend that high-risk individuals be screened for S. stercoralis prior to immunosuppressive therapy in endemic regions to raise awareness and prevent similar cases.
Identifiants
pubmed: 37532918
doi: 10.1007/s11686-023-00705-x
pii: 10.1007/s11686-023-00705-x
doi:
Substances chimiques
Ivermectin
70288-86-7
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
711-717Informations de copyright
© 2023. The Author(s) under exclusive licence to Witold Stefański Institute of Parasitology, Polish Academy of Sciences.
Références
Najafi N et al (2016) Disseminated Strongyloidiasis in an Iranian Immunocompromised Patient: A Case Report. Iran J Parasitol 11(2):279–283
pubmed: 28096866
pmcid: 5236109
Zheng JH, Xue LY (2022) Disseminated strongyloidiasis in a patient with rheumatoid arthritis: a case report. World J Clin Cases 10(18):6163–6167. https://doi.org/10.12998/wjcc.v10.i18.6163
doi: 10.12998/wjcc.v10.i18.6163
pubmed: 35949857
pmcid: 9254191
Tabei SZ et al (2009) Gastrointestinal hyper infection due to Strongyloides stercoralis in a patient with Behcet’s syndrome. Comp Clin Pathol 18(1):89–91. https://doi.org/10.1007/s00580-008-0750-2
doi: 10.1007/s00580-008-0750-2
Fakhar M et al (2010) Respiratory hyperinfection caused by Strongyloides stercoralis in a patient with pemphigus vulgaris and minireview on diagnosis and treatment of strongyloidiasis. Comp Clin Pathol 19(6):621–625. https://doi.org/10.1007/s00580-010-0995-4
doi: 10.1007/s00580-010-0995-4
Tebib N et al (2023) Prevalence and risk factors of Strongyloides stercoralis in haemodialysis in Cochabamba, Bolivia: a cross-sectional study. BMC Nephrol 24(1):27. https://doi.org/10.1186/s12882-023-03074-9
doi: 10.1186/s12882-023-03074-9
pubmed: 36750775
pmcid: 9903486
Kia EB et al (2008) A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate. Korean J Parasitol 46(4):261–263. https://doi.org/10.3347/kjp.2008.46.4.261
doi: 10.3347/kjp.2008.46.4.261
pubmed: 19127333
pmcid: 2612612
Siddiqui AA, Berk SL (2001) Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 33(7):1040–1047. https://doi.org/10.1086/322707
doi: 10.1086/322707
pubmed: 11528578
Catalano C et al (2017) Colorectal cancer associated with Strongyloides stercoralis colitis. ACG Case Rep J. https://doi.org/10.14309/crj.2017.104
doi: 10.14309/crj.2017.104
pubmed: 28879209
pmcid: 5577239
Heydarian P et al (2019) A case of fatal disseminated strongyloidiasis accompanied with intestinal obstruction. Oxf Med Case Rep 2019(10):omz087. https://doi.org/10.1093/omcr/omz087
doi: 10.1093/omcr/omz087
Xu L et al (2022) Pulmonary Infection Caused by Strongyloides stercoralis. Acta Parasitol 67(2):1044–1048. https://doi.org/10.1007/s11686-022-00527-3
doi: 10.1007/s11686-022-00527-3
pubmed: 35175460
Pecorella I et al (2022) Is Gastric Involvement by Strongyloides stercoralis in an Immunocompetent Patient a Common Finding? A Case Report and Review of the Literature. Acta Parasitol 67(1):94–101. https://doi.org/10.1007/s11686-021-00438-9
doi: 10.1007/s11686-021-00438-9
pubmed: 34143401
Khan U et al (2022) A case of Strongyloides stercoralis induced duodenitis and pancreatitis. IDCases 27:e01442. https://doi.org/10.3390/jcm11061597
doi: 10.3390/jcm11061597
pubmed: 35198385
pmcid: 8844764
Buonfrate D et al (2020) The global prevalence of Strongyloides stercoralis infection. Pathogens. https://doi.org/10.1016/j.jmii.2018.10.001
doi: 10.1016/j.jmii.2018.10.001
pubmed: 32545787
pmcid: 7349647
Davoodi L et al (2021) Strongyloides stercoralis, a neglected parasite in north of Iran with remarkable exposure. Gene Rep 24:101271. https://doi.org/10.1016/j.genrep.2021.101271
doi: 10.1016/j.genrep.2021.101271
Varatharajalu R, Rao KV (2016) Strongyloides stercoralis: current perspectives. Rep Parasitol 5:23–33. https://doi.org/10.2147/RIP.S75839
doi: 10.2147/RIP.S75839
Ganesh S, Cruz RJ Jr (2011) Strongyloidiasis: a multifaceted disease. Gastroenterol Hepatol (NY) 7(3):194–196
Keiser PB, Nutman TB (2004) Strongyloides stercoralis in the immunocompromised population. Clin Microbiol Rev 17(1):208–217
doi: 10.1128/CMR.17.1.208-217.2004
pubmed: 14726461
pmcid: 321465
Yaldiz M et al (2009) Gastric infection by Strongyloides stercoralis: a case report. Turk J Gastroenterol 20(1):48–51
pubmed: 19330735
Czeresnia JM, Weiss LM (2022) Strongyloides stercoralis. Lung 200(2):141–148
doi: 10.1007/s00408-022-00528-z
pubmed: 35396957
pmcid: 8994069
Alhaidar MK et al (2022) Current treatment of myasthenia gravis. J Clin Med 11(6):1597
doi: 10.3390/jcm11061597
pubmed: 35329925
pmcid: 8950430
Taheri A et al (2022) New-onset myasthenia gravis after novel coronavirus 2019 infection. Respirol Case Rep 10(6):e0978. https://doi.org/10.3390/jcm11061597
doi: 10.3390/jcm11061597
pubmed: 35620352
pmcid: 9125167
Feely NM et al (2010) Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. Anaesthesia 65(3):298–301. https://doi.org/10.1111/j.1365-2044.2009.06196
doi: 10.1111/j.1365-2044.2009.06196
pubmed: 20003112
Cruz T, Reboucas G, Rocha H (1966) Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med 275(20):1093–1096
doi: 10.1056/NEJM196611172752003
pubmed: 5925209
Karanam LS, Basavraj GK, Papireddy CKR (2020) Strongyloides stercoralis hyper infection syndrome. Indian J Surg 83(Suppl 3):1–5. https://doi.org/10.1007/s12262-020-02292
doi: 10.1007/s12262-020-02292
Mitra S et al (2022) Role of neglected parasitic diseases in the era of COVID-19 pandemics. Annal Parasitol 68(4):667–672. https://doi.org/10.17420/ap6804.473
doi: 10.17420/ap6804.473
Shafaghi A et al (2012) Gastric strongyloidiasis as multiple small gastric nodules. Am J Case Rep 13:7–10. https://doi.org/10.12659/ajcr.882279
doi: 10.12659/ajcr.882279
pubmed: 23569473
pmcid: 3615914
Sharifdini M et al (2014) An analysis of clinical characteristics of Strongyloides stercoralis in 70 indigenous patients in Iran. Iran J Parasitol 9(2):155–162
pubmed: 25848380
pmcid: 4386034
Oktar N, Ozer HM, Demirtas E (2020) Central nervous system Strongyloides stercoralis. A case report. Turk Neurosurg 30(5):776–779. https://doi.org/10.5137/1019-5149.Jtn.22886-18.2
doi: 10.5137/1019-5149.Jtn.22886-18.2
pubmed: 30649819
Newberry AM et al (2005) Strongyloides hyperinfection presenting as acute respiratory failure and gram-negative sepsis. Chest 128(5):3681–3684. https://doi.org/10.1378/chest.128.5.3681
doi: 10.1378/chest.128.5.3681
pubmed: 16304332
Mejia R, Nutman TB (2012) Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis 25(4):458–463. https://doi.org/10.1097/QCO.0b013e3283551dbd
doi: 10.1097/QCO.0b013e3283551dbd
pubmed: 22691685
pmcid: 3430846
Yingklang M et al (2022) Association of Strongyloides stercoralis infection and type 2 diabetes mellitus in northeastern Thailand: Impact on diabetic complication-related renal biochemical parameters. PLoS ONE 17(5):e0269080. https://doi.org/10.1371/journal.pone.0269080
doi: 10.1371/journal.pone.0269080
pubmed: 35639713
pmcid: 9154194
Rajamanickam A et al (2018) Metabolic consequences of concomitant Strongyloides stercoralis infection in patients with type 2 diabetes mellitus. Clin Infect Dis 69(4):697–704. https://doi.org/10.1093/cid/ciy935
doi: 10.1093/cid/ciy935
pmcid: 6669314
Hays R et al (2015) Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? Evidence from Australian Aboriginal adults. Diabetes Res Clin Pract 107(3):355–361. https://doi.org/10.1016/j.diabres.2015.01.012
doi: 10.1016/j.diabres.2015.01.012
pubmed: 25656764
Wiria AE et al (2015) Infection with soil-transmitted helminths is associated with increased insulin sensitivity. PLoS ONE 10(6):e0127746. https://doi.org/10.1371/journal.pone.0127746
doi: 10.1371/journal.pone.0127746
pubmed: 26061042
pmcid: 4464734
Wolde M et al (2019) Inverse Associations of Schistosoma mansoni Infection and Metabolic Syndromes in Humans: A Cross-Sectional Study in Northeast Ethiopia. Microbiol Insights 12:1178636119849934. https://doi.org/10.1177/1178636119849934
doi: 10.1177/1178636119849934
pubmed: 31205419
pmcid: 6537292
Chen Y et al (2013) Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China. J Clin Endocrinol Metab 98(2):E283–E287. https://doi.org/10.1210/jc.2012-2517
doi: 10.1210/jc.2012-2517
pubmed: 23275524
Toledo R, Muñoz-Antoli C, Esteban JG (2015) Strongyloidiasis with emphasis on human infections and its different clinical forms. Adv Parasitol 88:165–241. https://doi.org/10.1016/bs.apar.2015.02.005
doi: 10.1016/bs.apar.2015.02.005
pubmed: 25911368
Ramanathan R, Nutman T (2008) Strongyloides stercoralis infection in the immunocompromised host. Curr Infect Dis Rep 10(2):105–110. https://doi.org/10.1007/s11908-008-0019-6
doi: 10.1007/s11908-008-0019-6
pubmed: 18462583
pmcid: 3401551
Zaghlool DA et al (2016) A case of fatal gastrointestinal haemorrhage due to hyperinfection with Strongyloides stercoralis. J Parasit Dis 40(4):1347–1350. https://doi.org/10.1007/s12639-015-0687-8
doi: 10.1007/s12639-015-0687-8
pubmed: 27876945
Costa Silva R et al (2021) Strongyloides stercoralis Gastric Ulcer: A Rare Cause of Upper Gastrointestinal Bleeding. GE Port J Gastroenterol 28(4):274–278. https://doi.org/10.1159/000509195
doi: 10.1159/000509195
pubmed: 34386555
Mora CS, Segami MI, Hidalgo JA (2006) Strongyloides stercoralis hyperinfection in systemic lupus erythematosus and the antiphospholipid syndrome. Semin Arthritis Rheum 36(3):135–143. https://doi.org/10.1016/j.semarthrit.2006.06.001
doi: 10.1016/j.semarthrit.2006.06.001
pubmed: 16949135
Pacanowski J et al (2005) Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report. Am J Trop Med Hyg 73(1):122–124
doi: 10.4269/ajtmh.2005.73.122
pubmed: 16014846
Ostera G et al (2017) Strongyloidiasis in Latin American immigrants: a pilot study. J Helminthol 91(2):262–266. https://doi.org/10.1017/s0022149x16000213
doi: 10.1017/s0022149x16000213
pubmed: 27121364
Vadlamudi RS, Chi DS, Krishnaswamy G (2006) Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy 4:8. https://doi.org/10.1186/1476-7961-4-8
doi: 10.1186/1476-7961-4-8
pubmed: 16734908
pmcid: 1538622
Wurtz R et al (1994) Short report: gastric infection by Strongyloides stercoralis. Am J Trop Med Hyg 51(3):339–340. https://doi.org/10.4269/ajtmh.1994.51.339
doi: 10.4269/ajtmh.1994.51.339
pubmed: 7943554
Kim J et al (2003) A case of gastric strongyloidiasis in a Korean patient. Korean J Parasitol 41(1):63–67. https://doi.org/10.3347/kjp.2003.41.1.63
doi: 10.3347/kjp.2003.41.1.63
pubmed: 12666732
pmcid: 2717484
Saraei M et al (2014) Fatal Strongyloides hyper-infection in a patient with myasthenia gravis. Infection 42(6):1039–1042. https://doi.org/10.1007/s15010-014-0637-x
doi: 10.1007/s15010-014-0637-x
pubmed: 24871626
Shekhar KC et al (1997) Gastric strongyloidiasis in a Malaysian patient. Southeast Asian J Trop Med Public Health 28(1):158–160
pubmed: 9322300
Jenks NP et al (2022) T. Strongyloidiasis hyperinfection syndrome in COVID-19 positive migrants treated with corticosteroids. J Immigr Minor Health 24(6):1431–1434. https://doi.org/10.1007/s10903-022-01386
doi: 10.1007/s10903-022-01386
pubmed: 35939223
pmcid: 9358917
Jones N et al (2010) Pancreatitis associated with Strongyloides stercoralis infection in a patient chronically treated with corticosteroids. J Intensive Care Med 25(3):172–174. https://doi.org/10.1177/0885066609359992
doi: 10.1177/0885066609359992
pubmed: 20444734
Dourmishev AL, Dourmishev LA, Schwartz RA (2005) Ivermectin: pharmacology and application in dermatology. Int J Dermatol 44(12):981–988. https://doi.org/10.1111/j.1365-4632.2004.02253
doi: 10.1111/j.1365-4632.2004.02253
pubmed: 16409259